Search form
Search
contact us
Navigation
home
boards
job center
job ratings
cp wire
device news
pharmagather
catering
advertise
Legal Help
login/register
You are here
Home
»
companies
» Defactinib
Defactinib
The top 10 biopharma pipeline disasters of 2015
The top 10 biopharma pipeline disasters of 2015
Fierce Biotech
Eli Lilly
GSK
AstraZeneca
Shire
Celladon
Takeda
Merck
Roche
Verastem
evacetrapib
Breo Ellipta
brodalumab
selumetinib
SHP625
Mydicar
Alisertib
suggammadex
sembragiline
Defactinib
Flag link:
Verastem concedes lead drug flopped in PhII mesothelioma study
Verastem concedes lead drug flopped in PhII mesothelioma study
Fierce Biotech
Verastem
mesothelioma
Defactinib
clinical trials
Flag link:
Verastem Initiates Phase 2 Trial of Defactinib in Lung Cancer
Verastem Initiates Phase 2 Trial of Defactinib in Lung Cancer
Yahoo
Defactinib
Verastem
non-small cell lung cancer
Flag link:
Verastem Reports on Ongoing Trials at Cancer Advance at Harvard Medical School
Verastem Reports on Ongoing Trials at Cancer Advance at Harvard Medical School
Yahoo
clinical trials
Harvard
Verastem
Defactinib
mesothelioma
Flag link:
Verastem: An Attractive Long-Term Investment In The Cancer Stem Cell Space
Verastem: An Attractive Long-Term Investment In The Cancer Stem Cell Space
Seeking Alpha
stem cells
cancer
Verastem
VS-4718
Defactinib
VS-5584
Flag link:
